CorMedix, Inc. (CRMD)
CorMedix Market Cap : 383.08M for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 383.08M |
| November 13, 2026 | 370.36M |
| November 12, 2026 | 384.67M |
| November 11, 2026 | 421.23M |
| November 10, 2026 | 426.79M |
| November 09, 2026 | 424.84M |
| November 06, 2026 | 413.19M |
| November 05, 2026 | 406.20M |
| November 04, 2026 | 439.60M |
| November 03, 2026 | 431.83M |
| November 02, 2026 | 418.63M |
| October 30, 2026 | 442.31M |
| October 29, 2026 | 593.38M |
| October 28, 2026 | 636.87M |
| October 27, 2026 | 621.34M |
| October 26, 2026 | 616.68M |
| October 23, 2026 | 609.69M |
| October 22, 2026 | 629.10M |
| October 21, 2026 | 605.03M |
| October 20, 2026 | 587.94M |
| October 19, 2026 | 573.18M |
| October 16, 2026 | 563.86M |
| October 15, 2026 | 579.40M |
| October 14, 2026 | 573.96M |
| October 13, 2026 | 573.96M |
| Date | Value |
|---|---|
| October 12, 2026 | 579.40M |
| October 09, 2026 | 573.18M |
| October 08, 2026 | 568.52M |
| October 07, 2026 | 565.42M |
| October 06, 2026 | 565.42M |
| October 05, 2026 | 563.86M |
| October 02, 2026 | 558.43M |
| October 01, 2026 | 576.29M |
| September 30, 2026 | 598.04M |
| September 29, 2026 | 615.90M |
| September 28, 2026 | 612.79M |
| September 25, 2026 | 609.69M |
| September 24, 2026 | 603.47M |
| September 23, 2026 | 597.26M |
| September 22, 2026 | 604.25M |
| September 21, 2026 | 603.47M |
| September 18, 2026 | 599.59M |
| September 17, 2026 | 605.03M |
| September 16, 2026 | 607.36M |
| September 15, 2026 | 602.70M |
| September 14, 2026 | 612.79M |
| September 11, 2026 | 607.74M |
| September 10, 2026 | 618.23M |
| September 09, 2026 | 631.43M |
| September 08, 2026 | 635.32M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 23.53M |
| Eloxx Pharmaceuticals, Inc. | 51.46M |
| Breakthrough Chemistry, Inc. | 0.72M |
| BioStem Technologies, Inc. | 17.92M |
| Cardiac Biotech Solutions, Inc. | 5.880M |
Market Cap Related Metrics
| PE Ratio | 7.329 |
| PS Ratio | 1.045 |
| Price to Book Value | 0.8297 |
| Price to Free Cash Flow | 1.403 |
| Price | 4.82 |
| Earnings Yield | 13.65% |
| Operating PE Ratio | 2.711 |
| Normalized PE Ratio | 5.649 |